Canada must investigate why Big Pharma price gouging is keeping life-saving medicine from kids
In the midst of a ferocious RSV season that has seen pediatric hospitals swamped with severely ill children, The Council of Canadians is calling on the federal government and the Patented Medicines Price Review Board (PMPRB) to immediately launch an inquiry into the high price of Synagis, a drug that prevents RSV in at-risk infants. Read more.
Contact Minister for Health Jean-Yves Duclos, Prime Minister Justin Trudeau, and your MP and urge the federal government to take action now. A copy of your letter will be sent to Richard Gonzalez, CEO of AbbVie, the pharmaceutical company who produces the RSV drug.